The effects of various agents targeting these gastrointestinal peptide systems ... well along in clinical development. Liraglutide (NN2211) is a GLP-1 receptor agonist that is administered ...

Objective: To review drug interaction studies of glucagon-like peptide-1 receptor agonists (GLP-1RAs ... using the terms exenatide, liraglutide, albiglutide, and lixisenatide.

Glucagon-like peptide ... GLP-1 hormone plays a role in appetite regulation. GLP-1 RAs can cause feelings of early fullness, as well as nausea, vomiting, and diarrhea. A higher dose of liraglutide ...

The drug, called liraglutide, is one of the glucagon-like peptide receptor (GLP-1) agonists which also includes ... of their brains to evaluate structure and volume, as well as having glucose ...

Lexaria Bioscience (LEXX) provides a glucagon-like peptide-1 strategic update following important industry developments reported both by Pfizer ...

A new study from Rutgers University links higher body dissatisfaction, BMI, and maladaptive weight loss behaviors with ...

The rapid increase in the use of glucagon-like peptide-1 receptor agonists for weight loss, diabetes management and ...